Delivery Order SPE2DE22D0008-SPE2D626F35E4
Award Date 12/17/25
Potential Completion Date 12/22/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no...
- Alba Bioscience, Inc., a Chicago-based diagnostic supplier specializing in immunohematology reagents and blood banking materials, was awarded a $4,740 delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 30, 2025, for ALBACLONE Anti-B monoclonal antibodies. The contract, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by November 4, 2025, and will be performed in Chicago, Illinois. This delivery order represents a...
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,150 to Alba Bioscience, Inc. for ALBACYTE Antibody Screen (2-Cell) products, with an ultimate completion date of October 9, 2025. Alba Bioscience, a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was selected through a non-set-aside competitive process. The delivery order falls under the company's existing blanket purchase agreements with the Department of Veterans Affairs, which...
- This is a federal contract award to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $4,886.95, is a delivery order issued by the Defense Logistics Agency Troop Support Medical for the supply of ALBACLONE Anti-S (Big S) blood bank products. The contract has a firm fixed-price pricing type and...
- This federal contract award with ID SPE2DE22D0008|SPE2D625F23XA was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The $22,550.00 firm fixed-price contract is for the delivery of ALBACLONE Anti-D Blend products, which are specialized blood banking reagents and diagnostic materials used for blood typing and transfusion services in federal healthcare facilities. The contract...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract is a Delivery Order worth $4,740.00 for ALBACLONE Anti-A products, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense and other federal healthcare systems. The contract has a firm fixed-price pricing type and an ultimate completion date of July...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, is for the delivery of ALBACLONE Anti-A blood banking products with a ceiling value of $1,118.00. The contract is a Firm Fixed Price Delivery Order and has an ultimate...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...